Cluster analysis of high-cost patients in Japan: A longitudinal study using health insurance data.
Researchers
Yoko Matsuo, Keita Yamauchi
Abstract
This study aimed to identify distinct patterns of medical expenditure trajectories among high-cost patients in Japan and characterise the identified groups using diagnostic and health check-up data, including laboratory test results. This retrospective study analysed data from 190,190 high-cost patients (top 5% of annual medical expenditure in fiscal year 2021) in the Japanese JMDC Claims Database. Five-year healthcare expenditure trajectories were classified using K-means clustering. The resulting clusters were characterised according to demographic characteristics, disease patterns, hospitalisation rates, and health check-up data. Eighteen clusters were identified and further grouped into four descriptive types of expenditure trajectory. The 'over-30-million-yen (200,000 USD)' type included two clusters with rare, high-cost diseases such as haematological disorders, chronic viral hepatitis, and sphingolipid metabolism disorders. The 'flat' type (four clusters) showed relatively smooth expenditure patterns over time, associated with chronic conditions like dialysis and secondary cancers. In contrast, the 'gradual peak' type exhibited costs that increased over time, largely due to malignant neoplasms. Meanwhile, the 'sharp peak' type was characterised by sudden cost surges driven primarily by inpatient care, with a high prevalence of angina and atrial fibrillation. By analysing five-year expenditure trajectories at the individual level, this study identified distinct longitudinal patterns and provided a descriptive framework for understanding heterogeneity among high-cost patients.Source: PubMed (PMID: 43050460)View Original on PubMed